The global Uveitis Treatment Market is estimated to be valued at US$ 710.0 Mn in 2022 and is expected to exhibit a CAGR of 5.3% over the forecast period (2022-2030).
Uveitis is an inflammatory condition that affects the uvea, which is the middle layer of the eye that contains blood vessels that supply the retina. The uvea also includes the iris (the colored part of the eye), the ciliary body (which produces the fluid inside the eye), and the choroid (which supplies blood to the retina).
Treatment for uveitis depends on the underlying cause and the severity of the inflammation. It may include the use of topical or oral corticosteroids to reduce inflammation, immunosuppressive drugs to prevent the immune system from attacking the eye, and biological agents that target specific components of the immune system. In severe cases, surgery may be necessary to treat complications such as cataracts or glaucoma that can develop as a result of uveitis.
Over the forecast period, the high prevalence of uveitis is anticipated to drive growth in the worldwide Uveitis Treatment Market. The Pacific Ocular Inflammation Study, for example, reported a uveitis incidence of 24.9 cases per 100,000 person-years, while the Northern California study revealed a uveitis incidence of 52.4 cases per 100,000 person-years.
Over the forecast period, it is anticipated that the rising frequency of autoimmune illnesses will boost the expansion of the worldwide Uveitis Treatment Market. For instance, a research from John Hopkins University's department of pathology estimates that the total number of Americans affected by autoimmune disorders each year is roughly 10 million, or 3% of the country's population.
Read More- https://cmi-latestreportorientedblogs.blogspot.com/2023/04/the-global-uveitis-treatment-market.html
Uveitis Treatment Market is valued around USD 475.7 Million in 2018 and expected to reach USD 724.8 Million by 2025 with the CAGR of 6.2% over the forecast period.Increasing demand for advanced healthcare products and rising number of patients affected by Cataract and other eye related diseases are some factors driving the growth of Global Uveitis Treatment Market.
Get Sample Copy of The Activated Alumina Market Report 2020@ https://brandessenceresearch.com/requestSample/PostId/554*The sample pages of this report is immediately accessible on-demand.
** Uveitis Treatment Leading Market PlayersAllerganBausch & LombNovartisAbbVieSanten PharmaceuticalEyegate PharmaceuticalsAlimera Sciences Uveitis disease directly affects the eyes and the most common symptoms of uveitis are eye inflammation and swelling that can destroy eye tissues.
The Iris is colored circle at the front of eye, the ciliary body helps to focus eye lens and makes fluid that nourishes inside of eye and the choroid is group of blood vessels which gives the nutrition’s to the retina it needs.
People who are suffering from AIDS, Ankylosing spondylitis, Behcet’s disease, CMV retinitis, Herpes zoster infection, Histoplasmosis, Kawasaki disease, Multiple sclerosis, Psoriasis, Reactive arthritis, Rheumatoid arthritis etc.
On the basis of country level, market of Uveitis Treatment is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.Key Players–Global Uveitis Treatment Market report covers prominent players like Allergan, Bausch & Lomb, Novartis, AbbVie, Santen Pharmaceutical, Eyegate Pharmaceuticals, Alimera Sciences.Market Dynamics- Advanced technological requirements in healthcare, increasing disposable income and high expenditure on healthcare are some of the factors driving the market of uveitis treatment.
